Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Down 84.4% in July

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 7,564 shares, a decline of 84.4% from the July 15th total of 48,491 shares. Based on an average daily volume of 247,388 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 0.1%

Shares of SGIOY opened at $8.87 on Wednesday. The business’s 50-day moving average price is $8.78 and its 200 day moving average price is $9.87. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $15.10 billion, a P/E ratio of 8.87, a P/E/G ratio of 3.49 and a beta of 0.08. Shionogi & Co., Ltd. Unsponsored ADR has a 1-year low of $7.65 and a 1-year high of $12.00.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings data on Monday, August 3rd. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.47%. Analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently commented on SGIOY. The Goldman Sachs Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Zacks Research raised Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a report on Monday, May 25th. Finally, Jefferies Financial Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy”.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.